Hikma Pharmaceuticals Reports Strong Start to 2024 Across All Business Segments, Confirms Full Year Guidance
Consistent Growth and Expanded Market Reach Highlight Early Success; Final Dividend Announced London, UK— This Thursday, Hikma Pharmaceuticals PLC provided a trading update…